INNOVUS PHARMACEUTICALS, INC. — Revenue by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/a90540ec-2259-4227-b68d-0439b45700a2/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2018 | $24.0M | 2018-01-01 – 2018-12-31 | evidence 0001437749-19-006219 |
| FY 2017 | $8.8M | 2017-01-01 – 2017-12-31 | evidence 0001437749-19-006219 |
| FY 2016 | $4.8M | 2016-01-01 – 2016-12-31 | evidence 0001654954-17-001819 |
| FY 2015 | $730.7k | 2015-01-01 – 2015-12-31 | evidence 0001415889-16-005397 |
| FY 2014 | $655.1k | 2014-01-01 – 2014-12-31 | evidence 0001415889-15-001153 |
| FY 2013 | $6.6k | 2013-01-01 – 2013-12-31 | evidence 0001415889-15-001153 |
| FY 2012 | $0 | 2008-11-01 – 2013-03-31 | evidence 0001144204-13-028024 |
| FY 2011 | $0 | 2011-01-01 – 2011-12-31 | evidence 0001144204-13-017983 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
INNOVUS PHARMACEUTICALS, INC. — all facts · Net Income · Operating Income